The abstract is read at the publisher; the summary is JClub's.
In adults with type 1 diabetes and end-stage kidney disease, SPKTx vs KTx is linked to lower post-transplant total cholesterol (-0.41 mmol/l) and triglycerides (-0.76 mmol/l).
- Why it matters: It addresses uncertainty about whether simultaneous pancreas-kidney transplantation improves metabolic status and macrovascular outcomes compared with kidney transplantation alone.
- What they did: A systematic review and meta-analysis of 15 retrospective/case-control studies (n=564 SPKTx, 419 KTx) pooled post-transplant outcomes for lipids, HbA1c, blood pressure, and renal function, plus CAD, CeVD, and PVD events.
- The result: SPKTx showed lower LDL (-0.28 mmol/l), HbA1c (-28.79 mmol/mol; -2.61%), and creatinine (-21.54 μmol/l) than KTx, but post-transplant CAD/CeVD/PVD frequencies did not differ between groups, while PVD drove the greatest macrovascular burden.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.